9.02
price down icon4.55%   -0.43
after-market After Hours: 9.02
loading

Newamsterdam Pharma Company N V Stock (NAMSW) Forecast

The Newamsterdam Pharma Company N V (NAMSW) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $8.0624, representing a -10.62% decrease from the current price of $9.02. The highest analyst price target is $11.39, and the lowest is $4.7347.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NAMSW Price Target
Average 5.8259 (-35.41% Downside)
loading

Is Newamsterdam Pharma Company N V (NAMSW) A Buy Now?

Oscillators
Name Value Action
RSI(14) 40.30 Neutral
STOCH(9,6) 32.05 Neutral
STOCHRSI(14) 68.05 Neutral
MACD(12,26) 0.7895 Sell
ADX(14) 58.58 Buy
William %R -92.57 Buy
CCI(14) -125.40 Sell
Buy: 2 Sell: 2 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
12.46
Sell
11.51
Sell
MA20
11.11
Sell
11.07
Sell
MA50
8.8721
Buy
9.7583
Sell
MA100
8.6963
Buy
9.1302
Sell
MA200
8.2532
Buy
0.00
Buy
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, NAMSW could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 8 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on NAMSW, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 40.3 indicates that NAMSW is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 32.05 indicates that NAMSW is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 68.05 indicates that NAMSW is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 58.58 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -125.4 indicates that NAMSW is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term NAMSW price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Newamsterdam Pharma Company N V financial reports and earnings history, Newamsterdam Pharma Company N V (NAMSW) stock could reach $13.05 by 2030, $87.03 by 2040 and $173.84 by 2050. See the projected annual prices until 2050 of the Newamsterdam Pharma Company N V stock below:

  • Newamsterdam Pharma Company N V (NAMSW) is expected to reach an average price of $34.29 in 2035, with a high prediction of $41.15 and a low estimate of $35.29. This indicates an $280.11% rise from the last recorded price of $9.02.
  • Newamsterdam Pharma Company N V (NAMSW) stock is projected to chart a bullish course in 2040, with an average price target of $69.41, representing an $669.55% surge from its current level. The forecast ranges from a conservative $72.28 to a sky-high $87.03.
  • Our analysts predict Newamsterdam Pharma Company N V (NAMSW) to jump 1,196% by 2045, soaring from $120.15 to an average price of $116.89, potentially reaching $139.64. While $120.15 is the low estimate, the potential upside is significant.
  • Newamsterdam Pharma Company N V (NAMSW) stock is expected to climb by 2050, reaching an average of $173.85, a $1,827% jump from its current level. However, a wide range of estimates exists, with high and low targets of $173.84 and $6.5545, respectively, highlighting the market's uncertainty.

Newamsterdam Pharma Company N V Stock (NAMSW) Year by Year Forecast

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2024

Our forecast for NAMSW stock price in 2024 now indicates an average price target of $7.335 with a high forecast of $14.67 and a low forecast of $0.00. The average prediction reflects an decrease of -18.68% from the last recorded price of $9.02.
Month Average Low High Change from today's price
December, 2024 $7.94 $4.7347 $11.39 -11.97%

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2025

Newamsterdam Pharma Company N V Stock (NAMSW) is expected to reach an average price of $5.7025 in 2025, with a high prediction of $11.14 and a low estimate of $0.2618. This indicates an -36.78% fall from the last recorded price of $9.02.
Month Average Low High Change from today's price
January, 2025 $9.4855 $7.2782 $10.49 +5.16%
February, 2025 $9.2119 $8.0136 $11.14 +2.13%
March, 2025 $4.4042 $4.7627 $5.6863 -51.17%
April, 2025 $3.1318 $0.2618 $8.0632 -65.28%
May, 2025 $6.515 $3.0591 $9.965 -27.77%
June, 2025 $7.9795 $6.1123 $9.3409 -11.53%
July, 2025 $8.9528 $7.4955 $10.75 -0.74%
August, 2025 $6.9951 $7.3536 $8.5363 -22.45%
September, 2025 $1.0591 $0.8091 $5.8609 -88.26%
October, 2025 $5.09 $1.2455 $8.54 -43.57%
November, 2025 $7.0727 $4.9464 $8.3045 -21.59%
December, 2025 $7.8455 $6.9773 $10.37 -13.02%

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2026

The predicted value for Newamsterdam Pharma Company N V (NAMSW) in 2026 is set at an average of $8.5829. Estimates vary from a peak of $17.09 to a trough of $0.0795, indicating an -4.85% surge from the present price of $9.02.
Month Average Low High Change from today's price
January, 2026 $9.586 $8.2136 $11.39 +6.28%
February, 2026 $1.0136 $3.0114 $5.8068 -88.76%
March, 2026 $3.8773 $0.0795 $4.2273 -57.01%
April, 2026 $6.1659 $0.4597 $7.2682 -31.64%
May, 2026 $7.4568 $6.4591 $9.9773 -17.33%
June, 2026 $13.19 $7.9545 $14.24 +46.26%
July, 2026 $3.0864 $5.2136 $12.18 -65.78%
August, 2026 $2.3227 $0.1727 $2.6727 -74.25%
September, 2026 $4.2918 $0.9653 $6.2318 -52.42%
October, 2026 $7.0682 $4.8891 $9.5887 -21.64%
November, 2026 $15.91 $7.6955 $17.09 +76.42%
December, 2026 $5.1591 $7.4159 $14.77 -42.80%

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Newamsterdam Pharma Company N V (NAMSW) is $11.53, with a high forecast of $22.79 and a low forecast of $0.2827. This indicates an +27.88% increase from the last price of $9.02.
Month Average Low High Change from today's price
January, 2027 $0.7682 $1.3818 $4.2323 -91.48%
February, 2027 $3.2555 $1.4486 $5.1955 -63.91%
March, 2027 $6.8327 $3.9823 $6.8327 -24.25%
April, 2027 $18.63 $6.2795 $19.94 +106.58%
May, 2027 $5.1182 $9.6182 $17.36 -43.26%
June, 2027 $3.9727 $4.9727 $6.1755 -55.96%
July, 2027 $2.2191 $0.2827 $4.1591 -75.40%
August, 2027 $6.3145 $3.0755 $6.3145 -29.99%
September, 2027 $21.35 $5.8909 $22.79 +136.74%
October, 2027 $7.3205 $11.82 $19.95 -18.84%
November, 2027 $5.6568 $6.6568 $8.1186 -37.29%
December, 2027 $1.1827 $0.3409 $3.1227 -86.89%

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2028

In 2028, Newamsterdam Pharma Company N V (NAMSW) is projected to reach an average price of $15.85, with a high projection of $31.34 and a low estimate of $0.355. This indicates an +75.67% rise from the last price of $9.02.
Month Average Low High Change from today's price
January, 2028 $5.7964 $2.1686 $5.7964 -35.74%
February, 2028 $25.65 $5.5023 $25.64 +184.37%
March, 2028 $9.5227 $14.02 $24.07 +5.57%
April, 2028 $7.3409 $8.3409 $10.06 -18.62%
May, 2028 $2.0491 $0.9545 $3.5455 -77.28%
June, 2028 $5.2782 $0.3836 $5.2782 -41.48%
July, 2028 $28.50 $5.1136 $28.49 +215.96%
August, 2028 $11.72 $16.22 $26.80 +29.99%
September, 2028 $9.025 $10.02 $12.01 +0.06%
October, 2028 $3.215 $2.25 $5.10 -64.36%
November, 2028 $4.76 $0.355 $4.76 -47.23%
December, 2028 $31.35 $4.725 $31.34 +247.56%

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2029

The 2029 price forecast for Newamsterdam Pharma Company N V Stock (NAMSW) is $18.76 on average, with a high prediction of $37.04 and a low estimate of $0.4755. This represents an +107.94% increase from the previous price of $9.02.
Month Average Low High Change from today's price
January, 2029 $20.20 $24.04 $29.52 +123.97%
February, 2029 $12.90 $13.26 $13.95 +43.06%
March, 2029 $4.3809 $3.5455 $9.6791 -51.43%
April, 2029 $2.7873 $0.5518 $3.0873 -69.10%
May, 2029 $34.20 $2.8318 $34.19 +279.16%
June, 2029 $22.53 $26.37 $32.24 +149.82%
July, 2029 $14.72 $15.08 $15.89 +63.16%
August, 2029 $5.5468 $4.8409 $11.36 -38.51%
September, 2029 $2.1395 $0.4755 $2.4395 -76.28%
October, 2029 $5.2227 $2.3136 $8.1318 -42.10%
November, 2029 $24.87 $28.70 $37.04 +175.67%
December, 2029 $16.53 $16.89 $17.83 +83.27%

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2030

Newamsterdam Pharma Company N V Stock (NAMSW) is expected to reach an average price of $21.52 in 2030, with a high forecast of $42.74 and a low forecast of $0.3018. This signifies an +138.57% surge from the last price of $9.02.
Month Average Low High Change from today's price
January, 2030 $6.7127 $6.1364 $13.05 -25.58%
February, 2030 $1.4918 $0.3018 $2.0591 -83.46%
March, 2030 $4.8341 $1.7955 $7.8727 -46.41%
April, 2030 $30.74 $34.01 $39.89 +240.80%
May, 2030 $18.34 $18.70 $26.48 +103.38%
June, 2030 $7.2818 $7.4318 $14.73 -19.27%
July, 2030 $0.6191 $1.0791 $5.3186 -93.14%
August, 2030 $3.9739 $0.3341 $7.6136 -55.94%
September, 2030 $33.20 $36.47 $42.74 +268.09%
October, 2030 $20.16 $20.52 $28.81 +123.48%
November, 2030 $8.5773 $8.7273 $16.42 -4.91%
December, 2030 $1.3964 $1.8564 $6.4845 -84.52%
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Cap:     |  Volume (24h):